Zobrazeno 1 - 10
of 138
pro vyhledávání: '"D. Newling"'
Autor:
J. W. A. Oosterhuis, F. J. W. Ten Kate, M. L. G. Janssen-Heijnen, R.F.M. Schapers, R.P.E. Pauwels, D. Newling
Publikováno v:
Journal of clinical pathology, 55(12), 900-905. BMJ Publishing Group
Aim: To test the prognostic value of the 1998 WHO/ISUP (World Health Organisation/International Society of Urologic Pathology) consensus classification system in Ta papillary urothelial neoplasms of the bladder. Methods: The histological slides of 32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7142b2114a405cf75ef7376370226e0
https://doi.org/10.1136/jcp.55.12.900
https://doi.org/10.1136/jcp.55.12.900
Autor:
J. Bosschieter, J. Nieuwenhuijzen, T. Van Ginkel, A. Vis, B. Witte, D. Newling, G. Beckers, R. Van Moorselaar
Publikováno v:
European Urology Supplements. 16:e2631
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aad1ed82faac60d0d50b0ab42552081b
https://doi.org/10.1016/s1569-9056(17)31790-6
https://doi.org/10.1016/s1569-9056(17)31790-6
Autor:
Ziya Kirkali, W. Hoekstra, Maurizio Brausi, H. Van Poppel, D. Newling, Laurence Collette, M Decoster
Publikováno v:
European Journal of Cancer. 37:884-891
The aim of this study was to assess whether the quality of the surgical act could be an important prognostic factor for patients undergoing radical prostatectomy. This study also aims to investigate whether the surgical quality can be assessed by any
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::216bf4582ffe5c86eb746ecb76203c3d
https://doi.org/10.1016/s0959-8049(01)00056-9
https://doi.org/10.1016/s0959-8049(01)00056-9
Publikováno v:
European Urology. 39:643-647
To assess the effect and tolerance of a 6-week course of intravesical valrubicin on a tumour intentionally left in the bladder (marker lesion) following incomplete transurethral resection of the bladder (TURBT).In a prospective phase II study, 40 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e47ef4b547e3567492d087612def409a
https://doi.org/10.1159/000052521
https://doi.org/10.1159/000052521
Autor:
L.J. Denis, F. Keuppens, P.H. Smith, P. Whelan, J.L. Carneiro de Moura, D. Newling, A. Bono, R. Sylvester, for the EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center
Publikováno v:
European Urology. 33:144-151
Objectives: This prospective, randomized phase III study was initiated to compare the efficacy and side effects of bilateral orchiectomy versus a combination of a luteinizing hormon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fc465ce8be0616ab2a1e15ba070bdaf
https://doi.org/10.1159/000019546
https://doi.org/10.1159/000019546
Autor:
C.J. Tyrrell, L. Denis, D. Newling, M. Soloway, K. Channer, I.D. Cockshott, null on behalf of the ‘Casodex’ Study Group
Publikováno v:
European Urology. 33:39-53
Objectives: To evaluate the efficacy, tolerability, endocrinological effects and the pharmacokinetics of CasodexTM, when given as monotherapy during daily dosing of 10–20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f900462720984126dadf0d58985bd17b
https://doi.org/10.1159/000019526
https://doi.org/10.1159/000019526
Publikováno v:
European Urology. 28:272-283
This report is the final analysis of an EORTC Genito-Urinary Group Phase III trial (Protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate 50 mg 3 times a day and stilboestrol 1 mg daily in the management of metastatic carcinom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bc795148359903a9cad701aae26a69d
https://doi.org/10.1159/000475067
https://doi.org/10.1159/000475067
Autor:
M. R. G. Robinson, D. Newling, P. H. Smith, R. Lockwood, I. Stevens, Richard Sylvester, D. Byar, M. de Pauw
Publikováno v:
European Urology. 27:110-116
This double-blind randomised phase III trial was designed to assess the effect of pyridoxine administration on the recurrence of Ta and T1 transitional cell tumours of the bladder. The trial accrued 291 patients and showed no significant difference b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d0b1c1c81e46f379d3aca218a2956fd
https://doi.org/10.1159/000475139
https://doi.org/10.1159/000475139
Autor:
F. Keuppens, C. Mahler, Peter Whelan, P. Ongena, Aldo V. Bono, M. R. G. Robinson, K. Vermeylen, Richard Sylvester, J. L. De Carneiro Moura, D. Newling, M. De Pauw, L. Denis
Publikováno v:
Cancer. 72:3863-3869
A total of 327 patients with metastatic prostate cancer were randomized to receive bilateral orchiectomy or treatment with Zoladex and flutamide. The trial aimed to evaluate subjective and objective time to progression, survival, and incidence and du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38d06b0305bcbe58974a35851c7f14e8
https://doi.org/10.1002/1097-0142(19931215)72:12+<3863::aid-cncr2820721720>3.0.co
https://doi.org/10.1002/1097-0142(19931215)72:12+<3863::aid-cncr2820721720>3.0.co
Publikováno v:
Journal of Urology. 150:1840-1844
A total of 171 patients with progressive metastatic prostate cancer following hormonal therapy was randomized to receive either 560 to 700mg. estramustine orally per day or 15mg./m.2 mitomycin C by intravenous infusion every 6 weeks. The patients wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291d73aec3e17d367f717d0b56c8f1dc
https://doi.org/10.1016/s0022-5347(17)35911-6
https://doi.org/10.1016/s0022-5347(17)35911-6